NICOLETTE CHRISTOPHER: Open Payments
NPI 1114442126 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 132 payments from 22 companies in 2025. Trend: 2023 $1,058 · 2024 $2,107 · 2025 $2,477
Food & beverage: $2,467Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $619 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $322 |
| ABBVIE INC. | 15 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $212 |
| Ferring Pharmaceuticals Inc. | 5 | $143 |
| Ardelyx, Inc. | 6 | $135 |
| Phathom Pharmaceuticals, Inc. | 3 | $85 |
| GENZYME CORPORATION | 3 | $79 |
| Ipsen Biopharmaceuticals, Inc | 3 | $79 |
| Exact Sciences Corporation | 4 | $78 |
Products named: TREMFYA, XIFAXAN, REBYOTA, RINVOQ, ENTYVIO, IBSRELA, DUPIXENT, RELISTOR.
Industry payments across NY — which companies pay providers there.
